NCT02211651View on ClinicalTrials.gov

Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
ObesityType 2 Diabetes
Trial Locations (1)

32804

Translational Research Institute for Metabolism and Diabetes, Orlando

All Listed Sponsors
collaborator

Sanford-Burnham Medical Research Institute

OTHER

lead

AdventHealth Translational Research Institute

OTHER

NCT02211651 - Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM) | Biotech Hunter | Biotech Hunter